Pharma and Biotech
Traded | Action | Notifier | Price | Amount | Value |
---|---|---|---|---|---|
02-Nov-22 | Buy | Paul Carmelo Pagano | 130.00p | 5,000 | £6,500.00 |
Traded | Action | Notifier | Price | Amount | Value |
---|---|---|---|---|---|
02-Nov-22 | Buy | Paul Carmelo Pagano | 130.00p | 5,000 | £6,500.00 |
Notifier | Holding | Value* |
---|---|---|
Gordon Roy Davis | 14,204 | £11,008 |
Andrew Norman Boteler | 5,681 | £4,403 |
David Mark Anderson | 5,000 | £3,875 |
Paul Carmelo Pagano | 5,000 | £3,875 |
Notifier** | Holding | Value* |
---|---|---|
Killik & Co. | 25,480,790 | £19,747,612 |
Simon Raab | 4,148,293 | £3,214,927 |
Mount Sinai | 2,469,842 | £1,914,128 |
Octopus Investments Ltd | 1,968,750 | £1,525,781 |
Unicorn Asset Management | 1,750,000 | £1,356,250 |
Syno Ventures Master Fund, L.P. | 1,673,668 | £1,297,093 |
Frederick W. Gluck | 1,530,596 | £1,186,212 |
Livzon Pharmaceutical Group, Inc. | 1,347,653 | £1,044,431 |
Investec Wealth & Investment Limited | 1,265,289 | £980,599 |
Lombard Odier | 1,136,363 | £880,681 |
Accord Data Holdings Limited | 954,048 | £739,387 |
Currency | UK Pounds |
Share Price | 77.50p |
Change Today | 0.000p |
% Change | 0.00 % |
52 Week High | 177.50 |
52 Week Low | 75.00 |
Volume | 0 |
Shares Issued | 25.49m |
Market Cap | £19.75m |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
No dividends found |
You are here: research